B. Collado

Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog.

A. Bajo, A. Schally, A. Fernández-Martínez, 2005, International journal of oncology.

Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K

I. Gutiérrez-Cañas, A. Chiloeches, M. Juarranz, 2005, The Prostate.

Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells

M. Carmena, J. Prieto, M. Sánchez‐Chapado, 2006, Molecular and Cellular Endocrinology.

Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells

I. Gutiérrez-Cañas, J. Prieto, M. J. Carmena, 2004, Regulatory Peptides.

Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation.

I. Díaz-Laviada, M. Carmena, J. Prieto, 2005, Biochimica et biophysica acta.

Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.

A. M. Sánchez, M. Carmena, J. Prieto, 2005, European journal of pharmacology.

Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells

A. Bajo, M. Carmena, J. Prieto, 2007, Regulatory Peptides.

Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue

G. Bodega, M. Carmena, J. Prieto, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effects of Hypercholesterolaemia in the Retina

B. Collado, A. Casado, Maria B. Lopez, 2012 .

Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-κB in human prostate cell lines Differential time-dependent responses in cancer progression

A. Bajo, A. Fernández-Martínez, Ana B. Fernández-Martínez, 2007, Molecular and Cellular Endocrinology.

Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model

A. Bajo, M. Carmena, J. Prieto, 2007, Peptides.